Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
“Our 12-month price target of $20.00 per share implies shares could appreciate nearly four-fold over the next twelve months. OCEA’s valuation improvement prior to commercialization of its drug ...
Some people look at the sea as a relaxing playground, a place for champagne and caviar sunsets atop yacht decks following midday PWC frolics through crystal-clear waters. Others will happily give up ...
Providence, RI, March 14, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a next generation biopharma company, announces initiation of equity analyst coverage by EF Hutton with a “Buy” ...
French shipyard Ocea announced this week that it is partnering with Aldo Manna, head of the Ocea Mediterranean office in Italy, and designer Fulvio de Simoni on new project Nemo Ice. Manna tells us ...
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results